METHODS OF TREATING LUNG CANCER AND OTHER CANCERS BY RECOMBINANT SARS-COV-2 SPIKE S1

INHALABLE TARGETED GOLD NANOPARTICLE FOR ACCELERATED LUNG DELIVERY AND TREATING LUNG INFLAMMATION

Anti-Viral Therapeutic Peptides, Conjugates, and Methods of Use Thereof

NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

BROAD SPECTRUM INHIBITION OF HUMAN CORONAVIRUSES BY LIPOPEPTIDES DERIVED FROM THE C-TERMINAL HEPTAD REPEAT OF BETACORONAVIRUSES

ANTIVIRAL STRUCTURALLY-STAPLED SARS-CoV-2 PEPTIDE-CHOLESTEROL CONJUGATES AND USES THEREOF

MULTIEPITOPE SELF-ASSEMBLED NANOPARTICLE VACCINE PLATFORM (MSN-VACCINE PLATFORM) AND USES THERE OF

TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

METHODS FOR DEVELOPING CD3+CD8+ CELLS AGAINST MULTIPLE VIRAL EPITOPES FOR TREATMENT OF VIRAL INFECTIONS INCLUDING VARIANTS EVOLVING TO ESCAPE PREVIOUS IMMUNITY

NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

EXOSOMES COMPRISING CORONAVIRUS-DERIVED ANTIGEN PROTEIN OR GENE ENCODING SAME PROTEIN, AND USE OF SAME

CORONAVIRUS NEUTRALIZING COMPOSITIONS AND ASSOCIATED METHODS

NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

COMPOSITIONS AND METHODS FOR DOMINANT ANTIVIRAL THERAPY

ANTIVIRAL STRUCTURALLY-STABILIZED SARS-CoV-2 PEPTIDES AND USES THEREOF

MESENCHYMAL STROMAL CELLS AND EXTRACELLULAR VESICLES FOR TREATING VIRAL INFECTIONS, INFLAMMATION, AND TISSUE FIBROSIS

Peptides for the treatment of COVID-19

Anti-SARS-CoV-2 fusion peptides

Peptides for Covid-19 prevention and treatment

Methods and compositions for eliciting an immune response against hepatitis B virus

Human monoclonal antibodies against the middle east respiratory syndrome coronavirus (MERS-CoV) and engineered bispecific fusions with inhibitory peptides

Use of immune suppressive domains as medicaments

Methods and compositions for eliciting an immune response against hepatitis B virus